Bella Thorne Shows Off Curves In Animal Two-piece Bikini And Admits Hatred For Hollywood Weight Loss Drug Ozempic
The Hollywood weight loss drug Ozempic has been rife with several controversies as several celebrities are denying the use of the drug for their weight loss journey. But not Bella Thorne who has shown off her massive curves while on outings with her fiance, Mark Emms.
The star who seems to have gained a lot of weight has shared her disapproval noting that it has facilitated “crazy beauty standards” and made her quite self-conscious about her body. That’s because everyone is becoming so skinny courtesy of the drug although most end up denying it.
ALSO ON TBN: Bella Thorne Signs New Thriller Film Deal “FIND YOUR FRIENDS”: See Details
The Hollywood weight loss drug Ozempic was originally meant to help those suffering from diabetes but several celebrities are now using the drug for other purposes including losing weight. So far several celebrities such as Christina Aguilera, Rebel Wilson, Tori Spelling, Sharon Osborne, Tracy Morgan, Elon Musk etc have been associated with it.
Unlike them, Bella Thorne seems not to be enchanted with the drug as she shows off her curvy body in a clip of her rocking a two-piece animal print bikini in her Instagram story. She said, “So I haven’t been feeling good about my body in a while, especially with everybody on Ozempic.”
ALSO ON TBN: Bella Thorne Poses Up A Storm In Clingy Hooded Black Dress A Mammoth Film Festival
She further noted that she is under pressure as she can’t keep up with the thinness, the drug is promoting particularly as she has been exercising. “I have swam every day and I have sweat out everything possible and I have walked everywhere and I’m finally feeling good about myself.”
She flipped off the camera and concluded, “Finally feeling good. So Ozempic, you can [f–k] off.” It is worth noting that the Hollywood weight loss drug Ozempic has aided several celebrities in losing weight but they have never publicly shown support for the drug.
About The Author
